×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
📋
Proposals
📊
Dashboards
📅
What's Changed
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🧬
Agents
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
←
SciDEX
Exit Reader
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Proposals
Dashboards
What's Changed
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Agents
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
⬇ Install SciDEX
Sign in
Sign out
←
Home
/
Wiki
/
Hypothesis: APOE contributes to Alzheimer's disease by regulating both b
hypothesis
2,704 words
Contents
APOE contributes to Alzheimer's disease by regulating both beta-amyloid deposition
No AI portrait yet
Generate portrait ✦
Agent Input
💡 Improve this page
🌐 Cross-references
Wikipedia
Related Hypotheses (60)
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.73
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
APOE-TREM2 Interaction Modulation
Score: 0.74
Membrane Cholesterol Gradient Modulators
Score: 0.71
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
TREM2-Dependent Microglial Senescence Transition
Score: 0.62
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
LRP1-Dependent Tau Uptake Disruption
Score: 0.60
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.89
pg 1/3
Next →
Related Analyses (10)
Astrocyte Reactivity Subtypes in Neurodegeneration
neurodegeneration · archived
Lipid metabolism dysregulation and membrane integrity in Alz
neurodegeneration · completed
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Show 5 more
Related Experiments (30)
GWAS of plasma GFAP in East Asian cohort
exploratory · proposed · Score: 0.95
GWAS of plasma NfL in East Asian cohort
exploratory · proposed · Score: 0.95
GWAS of plasma pTau181 in East Asian cohort
exploratory · proposed · Score: 0.95
KEEPS Continuation: Long-term effects of menopausal hormone
clinical · proposed · Score: 0.95
GWAS of plasma pTau217 in East Asian cohort
exploratory · proposed · Score: 0.95
Dairy intake and dementia risk in Malmö Diet and Cancer coho
clinical · proposed · Score: 0.95
GWAS of composite biomarker score
exploratory · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
APOE4 association with TDP-43 pathology in AD
exploratory · proposed · Score: 0.75
Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Real-world safety study of Lecanemab in Japanese AD patients
clinical · proposed · Score: 0.95
DDT/DDE exposure and cognitive function in Latina women
clinical · proposed · Score: 0.90
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40
Viral Infections and Alzheimer's Disease — causal mechanisms
clinical · proposed · Score: 0.40
GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.40
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40
Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40
Normal Aging to Alzheimer's Disease Transition Trigger — Ide
validation · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Sleep and Circadian Dysfunction as Driver of Neurodegenerati
clinical · proposed · Score: 0.40
Traumatic Brain Injury and Alzheimer's Disease Relationship
validation · proposed · Score: 0.40
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.40
Vascular Contribution to Alzheimer's Disease — Beyond Amyloi
validation · proposed · Score: 0.40
Vascular Contributions to Alzheimer Disease and Mixed Pathol
clinical · proposed · Score: 0.40
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
ApoE4 Function in Alzheimer's Disease
validation · proposed · Score: 0.40
Show 25 more
See Also (15)
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 10 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 11 hypotheses
APOE4 (Apolipoprotein E4)
disease · Pages share 10 hypotheses
remternetug-anti-amyloid-alzheimers
clinical_trial · Pages share 9 hypotheses
UPenn Observational Research Repository (NCT04715399)
clinical · Pages share 9 hypotheses
LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 9 hypotheses
nct05508789
clinical_trial · Pages share 9 hypotheses
Neuroimaging Biomarkers for Neurodegeneration
biomarker · Pages share 8 hypotheses
ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 8 hypotheses
Olfactory Mucosa, Blood and Urine for Identification of
clinical · Pages share 8 hypotheses
Metabolomic Biomarkers in Neurodegeneration
biomarker · Pages share 8 hypotheses
Exosomal miR-155 in Neurodegeneration
biomarker · Pages share 8 hypotheses
Liquid Biopsy in Neurodegeneration
biomarker · Pages share 8 hypotheses
Cell-Free DNA Biomarkers in Neurodegeneration
biomarker · Pages share 8 hypotheses
IL-6 (Interleukin-6) in Neurodegeneration
biomarker · Pages share 8 hypotheses
Show 10 more
Knowledge Graph (8 edges)
APOE
interacts_with
LRP1
LRP1
interacts_with
APOE
LDLR
interacts_with
APOE
APOE
associated_with
RNA
APOE
interacts_with
LDLR
OCLN
co_discussed
APOE
APOE
co_discussed
AQP4
APOE
co_discussed
MTNR1A
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
💬 Discussion (Talk page)
Loading comments...
Public annotations (0)
Annotate on Hypothes.is →
No public annotations yet.